stockrowGain Therapeutics, Inc. (GANX) vs Serina Therapeutics, Inc. (SER)
- Gain Therapeutics, Inc. GANX 1.00 +4.17%
- Serina Therapeutics, Inc. SER 1.40 −15.15%
Gain Therapeutics, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Serina Therapeutics, Inc. are of similar size ($41.9M and $41.9M). Gain Therapeutics, Inc. grew revenue faster over the last twelve months: 18.4% against −94.2%. Across the 14 metrics below, Gain Therapeutics, Inc. leads on 7 and Serina Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | GANX | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (268.30%) | (306.22%) | (51.96%) |
| Return on assets | (159.22%) | (136.00%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack